NCT07508761 2026-04-02
IPG7236 Combined With Toripalimab in Participants With Advanced Solid Tumors
Nanjing Immunophage Biotech Co., Ltd
Phase 1/2 Not yet recruiting
Nanjing Immunophage Biotech Co., Ltd
Wigen Biomedicine Technology (Shanghai) Co., Ltd.
LaNova Medicines Limited